Metformin has been shown (134) to induce iron apoptosis and increase ROS levels in hepatocellular carcinoma cells via ATF4/STAT3, thereby decreasing hepatocellular carcinoma cell resistance to sorafenib. The gene discussed is ATF4; the disease is hepatocellular carcinoma.